[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 11, 2004

Effects of Estrogen-Only Treatment in Postmenopausal Women

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2004;292(6):683. doi:10.1001/jama.292.6.684-b

To the Editor: It is possible that the results of the WHI investigation1 may be explained in part by the action of estrogen on biological factors that increase breast cancer risk in postmenopausal women.2 Oral estrogens, through their metabolic action, oppose insulin resistance. Furthermore, through their hepatocellular actions, they cause an increase in sex hormone–binding globulin level, and a decrease in insulin-like growth factor I (IGF-I) activity, due to both a reduction in IGF-I level and an increase in IGF-binding protein-1 level.2 IGF-I is a potent mitogen for breast tissue and breast cancer cells.

First Page Preview View Large
First page PDF preview
First page PDF preview
×